Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
Health Technology » Pharmaceuticals Major
|JNJ||Johnson & Johnson||1.74%||176.97||0.7%||$1352.49m|
|BMY||Bristol-Myers Squibb Co.||0.36%||76.23||1.0%||$1197.90m|
|MRK||Merck & Co., Inc.||1.26%||93.25||0.7%||$1136.00m|
|LLY||Eli Lilly & Co.||4.49%||299.11||1.1%||$892.99m|
|BHVN||Biohaven Pharmaceutical Holding Co. Ltd.||0.65%||141.96||0.0%||$458.27m|
|HZNP||Horizon Therapeutics Plc||1.13%||90.35||5.4%||$200.40m|
|NVO||Novo Nordisk A/S||3.49%||107.68||0.1%||$190.60m|
Sunesis Pharmaceuticals, Inc. engages in the development and commercialization of new oncology therapeutics for the treatment of solid and hematologic cancers. The firm's activities include conducting research and development internally and through corporate collaborators, in-licensing and out-licensing pharmaceutical compounds and technology, conducting clinical trials and raising capital. The company was founded on February 10, 1998 and is headquartered in South San Francisco, CA.